Suppr超能文献

糖尿病对高危介入性冠状动脉手术预后的影响。

Impact of Diabetes Mellitus on Outcomes after High-Risk Interventional Coronary Procedures.

作者信息

Johannsen Laura, Soldat Julian, Krueger Andrea, Mahabadi Amir A, Dykun Iryna, Totzeck Matthias, Jánosi Rolf Alexander, Rassaf Tienush, Al-Rashid Fadi

机构信息

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Hospital Essen, Medical Faculty, 45147 Essen, Germany.

出版信息

J Clin Med. 2020 Oct 25;9(11):3414. doi: 10.3390/jcm9113414.

Abstract

An increasing number of patients with coronary artery disease are at high operative risk due to advanced age, severe comorbidities, complex coronary anatomy, and reduced ejection fraction. Consequently, these high-risk patients are often offered percutaneous coronary intervention (PCI) as an alternative to coronary artery bypass grafting (CABG). We aimed to investigate the outcome of patients with diabetes mellitus (DM) undergoing high-risk PCI. We analyzed consecutive patients undergoing high-risk PCI (period 01/2016-08/2018). In-hospital major adverse cardiac and cerebrovascular events (MACCEs), defined as in-hospital stroke, myocardial infarction and death, and the one-year incidence of death from any cause were assessed in patients with and without DM. There were 276 patients (age 70 years, 74% male) who underwent high-risk PCI. Eighty-six patients (31%) presented with DM (insulin-dependent DM: = 24; non-insulin-dependent DM: = 62). In-hospital MACCEs occurred in 9 patients (3%) with a non-significant higher rate in patients with DM ( = 5/86, 6% vs. = 4/190 2%; = 0.24). In patients without DM, the survival rate was insignificantly higher than in patients with DM (93.6% vs. 87.1%; = 0.07). One-year survival was not significantly different in DM patients with more complex coronary artery disease (SYNTAX I-score ≤ 22: 89.3% vs. > 22: 84.5%; = 0.51). In selected high-risk patients undergoing high-risk PCI, DM was not associated with an increased incidence of in-hospital MACCEs or a decreased one-year survival rate.

摘要

由于高龄、严重合并症、复杂的冠状动脉解剖结构以及射血分数降低,越来越多的冠心病患者手术风险很高。因此,这些高危患者常被提供经皮冠状动脉介入治疗(PCI)作为冠状动脉旁路移植术(CABG)的替代方案。我们旨在研究接受高危PCI的糖尿病(DM)患者的预后。我们分析了连续接受高危PCI的患者(2016年1月至2018年8月期间)。对有和没有DM的患者评估了住院期间主要不良心脑血管事件(MACCE),定义为住院期间中风、心肌梗死和死亡,以及任何原因导致的一年死亡率。有276例患者(年龄70岁,74%为男性)接受了高危PCI。86例患者(31%)患有DM(胰岛素依赖型DM:=24;非胰岛素依赖型DM:=62)。9例患者(3%)发生住院期间MACCE,DM患者发生率略高但无统计学意义(=5/86,6% vs. =4/190,2%;=0.24)。在没有DM的患者中,生存率略高于有DM的患者(93.6% vs. 87.1%;=0.07)。在冠状动脉疾病更复杂的DM患者中,一年生存率无显著差异(SYNTAX I评分≤22:89.3% vs. >22:84.5%;=0.51)。在选定的接受高危PCI的高危患者中,DM与住院期间MACCE发生率增加或一年生存率降低无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cab/7693790/bb183748065a/jcm-09-03414-g001.jpg

相似文献

1
3
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2826-2837. doi: 10.1016/j.jacc.2018.09.046.
7
Coronary Artery Bypass Surgery Improves Outcomes in Patients With Diabetes and Left Ventricular Dysfunction.
J Am Coll Cardiol. 2018 Feb 27;71(8):819-827. doi: 10.1016/j.jacc.2017.12.024.
8
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
J Thorac Cardiovasc Surg. 2021 Mar;161(3):1022-1031.e5. doi: 10.1016/j.jtcvs.2020.06.159. Epub 2020 Sep 16.

本文引用的文献

1
Safety and efficacy of a novel algorithm to guide decision-making in high-risk interventional coronary procedures.
Int J Cardiol. 2020 Jan 15;299:87-92. doi: 10.1016/j.ijcard.2019.07.080. Epub 2019 Jul 29.
2
2018 ESC/EACTS Guidelines on myocardial revascularization.
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
5
Management of Percutaneous Coronary Intervention Complications.
Curr Treat Options Cardiovasc Med. 2017 Apr;19(4):25. doi: 10.1007/s11936-017-0526-6.
7
Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure.
J Am Coll Cardiol. 2016 Aug 2;68(5):450-458. doi: 10.1016/j.jacc.2016.05.060.
10
Comparison of coronary artery bypass graft surgery and percutaneous coronary intervention in patients with diabetes.
Curr Treat Options Cardiovasc Med. 2015 May;17(5):377. doi: 10.1007/s11936-015-0377-y.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验